BIOLOGIC USE IN NHS PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Queen, Anton B. [1 ]
Siebert, Stefan [2 ]
机构：
[1] Univ Glasgow, Med, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
154
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] Golimumab: a guide to its use in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    Drugs & Therapy Perspectives, 2010, 26 (4) : 1 - 4
  • [2] Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Cantini, Fabrizio
    Niccoli, Laura
    Nannini, Carlotta
    Cassara, Emanuele
    Kaloudi, Olga
    Favalli, Ennio Giulio
    Becciolini, Andrea
    Benucci, Maurizio
    Gobbi, Francesca Li
    Guiducci, Serena
    Foti, Rosario
    Mosca, Marta
    Goletti, Delia
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (02) : 183 - 192
  • [3] ETANERCEPT RETENTION RATES IN PATIENTS WITH RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Dongen, C. V.
    Kneepkens, E.
    Vogelzang, E.
    l'Ami, M.
    Krieckaert, C.
    van der Horst, I.
    Voskuyl, A.
    Nurmohamed, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1145 - 1145
  • [4] Golimumab In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Oldfield, Vicki
    Plosker, Greg L.
    BIODRUGS, 2009, 23 (02) : 125 - 135
  • [5] GolimumabIn the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Vicki Oldfield
    Greg L. Plosker
    BioDrugs, 2009, 23 : 125 - 135
  • [6] CHANGING PATTERN OF THE USE OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Sanchez-Piedra, Carlos
    Prior-Espanol, Agueda
    Freire Gonzalez, Mercedes
    Colazo, Maria
    Ruiz-Montesinos, Dolores
    Perez-Vera, Yanira
    Ortiz, Ana
    Bustabad, Sagrario
    Vela-Casasempere, Paloma
    Rojas-Gimenez, Marta
    Sanchez-Alonso, Fernando
    Diaz-Gonzalez, Federico
    Jesus Gomez-Reino, Juan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1151 - 1152
  • [7] Infliximab Biosimilar use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients: The RHUMADATA Registry Experience
    Moura, Cristiano
    Choquette, Denis
    Coupal, Louis
    Bessette, Louis
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 819 - 819
  • [8] Does Maastricht Ankylosing Spondylitis Enthesitis Scores Differ between Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis Patients?
    Nilssen, Steffan Robstad
    Andersen, Jintana B.
    Vestaby, Hanne K.
    Haugeberg, Glenn
    Michelsen, Brigitte
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [9] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [10] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345